Vapotherm (NYSE:VAPO – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, May 3rd. Analysts expect Vapotherm to post earnings of ($0.41) per share for the quarter. Vapotherm has set its FY 2023 guidance at EPS. Vapotherm (NYSE:VAPO – Get Rating) last announced its quarterly earnings data […]
Vapotherm, Inc. , today announced that it will release financial results for the first quarter of 2023 after the close of trading on Wednesday, May 3, 2023. Vapotherm’s management team will. | April 27, 2023
Vapotherm, Inc. (NYSE:VAPO – Get Rating) was down 6.7% during mid-day trading on Monday . The stock traded as low as $0.61 and last traded at $0.62. Approximately 115,498 shares were traded during trading, a decline of 52% from the average daily volume of 240,402 shares. The stock had previously closed at $0.66. Vapotherm Stock […]
Vapotherm (NYSE:VAPO – Get Rating) and Artivion (NYSE:AORT – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations. Valuation & Earnings This table compares Vapotherm and Artivion’s gross revenue, […]
06.12.2022 - Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy products, which are used to treat patients of all . Seite 1